about
Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.Hexarelin Protects Rodent Pancreatic Β-Cells Function from Cytotoxic Effects of Streptozotocin Involving Mitochondrial Signalling Pathways In Vivo and In VitroHexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option.The CD36-PPARγ Pathway in Metabolic Disorders.Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The cardiovascular action of hexarelin.
@ast
The cardiovascular action of hexarelin.
@en
The cardiovascular action of hexarelin.
@nl
type
label
The cardiovascular action of hexarelin.
@ast
The cardiovascular action of hexarelin.
@en
The cardiovascular action of hexarelin.
@nl
prefLabel
The cardiovascular action of hexarelin.
@ast
The cardiovascular action of hexarelin.
@en
The cardiovascular action of hexarelin.
@nl
P2860
P1476
The cardiovascular action of hexarelin
@en
P2093
Ichiro Kishimoto
Takeshi Tokudome
P2860
P304
P356
10.11909/J.ISSN.1671-5411.2014.03.007
P50
P577
2014-09-01T00:00:00Z